Eiger BioPharmaceuticals, Inc. (EIGR): Price and Financial Metrics
EIGR Price/Volume Stats
| Current price | $1.73 | 52-week high | $43.35 |
| Prev. close | $1.90 | 52-week low | $1.10 |
| Day low | $1.66 | Volume | 137,800 |
| Day high | $1.90 | Avg. volume | 103,866 |
| 50-day MA | $5.29 | Dividend yield | N/A |
| 200-day MA | $11.59 | Market Cap | 2.55M |
EIGR Stock Price Chart Interactive Chart >
Eiger BioPharmaceuticals, Inc. (EIGR) Company Bio
Eiger BioPharmaceutical Inc, formerly Celladon Corporation, is a clinical-stage biotechnology company engaged in the development of cardiovascular gene therapy. The company was founded in 2008 and is based in Palo Alto, California.
EIGR Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | -83.29% |
| 3-year | -99.15% |
| 5-year | -99.51% |
| YTD | -74.31% |
| 2023 | -80.97% |
| 2022 | -77.26% |
| 2021 | -57.77% |
| 2020 | -17.52% |
| 2019 | 46.65% |
Loading social stream, please wait...